Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vernalis Seeks Buyers, CEO To Step Down, As US Commercial Strategy Disappoints

Executive Summary

Disappointing sales growth of its prescription extended-release cough-and-cold product has led Vernalis to decide to close down its US commercial operations, and to seek a buyer for the whole company.

 

Advertisement

Related Content

After Bad Data Comes Layoffs – Will The Next Job Cuts Be At Anthera?
Keeping Track Of CRLs: US FDA Again Faults Bausch + Lomb Manufacturing
Vernalis Raises $58m To Close Potential Funding Gap
Vernalis Raises $100 million To Support Push Into U.S. Rx Cough/Cold Market

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100575

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel